Page last updated: 2024-10-27

gliclazide and Drug Associated Myopathies

gliclazide has been researched along with Drug Associated Myopathies in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, KF1
Mak, MWH1
Lao, VWN1
Yip, HLK1
Lau, WY1
Wong, VTL1

Other Studies

1 other study available for gliclazide and Drug Associated Myopathies

ArticleYear
Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2020, Volume: 26, Issue:5

    Topics: Atorvastatin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Female; Gliclazid

2020